GDF2 and Alzheimer disease: We recentlydemonstrated that the immunoreactivity of activin receptor-like kinase 1 (ALK1), the typeI receptor for circulating BMP9/BMP10 (bone morphogenetic protein) signaling proteins, isreduced in advanced, but not early stages of AD in CA3 pyramidal neurons.